Literature DB >> 26207068

Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.

Silvio E Inzucchi1, David R Matthews2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26207068     DOI： 10.2337/dc15-0812

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

1.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Bio-Guided Isolation of Two New Hypoglycemic Triterpenoid Saponins from Polygonum capitatum.

Authors:  Doudou Huang; Zenan Du; Yanhong Chen; Feng Zhang; Zhiying Dong; Xiujuan Wang; Mengshuang Li; Wansheng Chen; Lianna Sun
Journal:  Drug Des Devel Ther       Date:  2021-12-14       Impact factor: 4.162

3.  The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study.

Authors:  Jin Bong Choi; Hyong Woo Moon; Young Hyun Park; Woong Jin Bae; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Kyung-Do Han; U-Syn Ha
Journal:  J Cancer       Date:  2016-10-22       Impact factor: 4.207

4.  Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study.

Authors:  Kotaro Iemitsu; Takashi Iizuka; Masahiro Takihata; Masahiko Takai; Shigeru Nakajima; Nobuaki Minami; Shinichi Umezawa; Akira Kanamori; Hiroshi Takeda; Takehiro Kawata; Shogo Ito; Taisuke Kikuchi; Hikaru Amemiya; Mizuki Kaneshiro; Atsuko Mokubo; Tetsuro Takuma; Hideo Machimura; Keiji Tanaka; Taro Asakura; Akira Kubota; Sachio Aoyagi; Kazuhiko Hoshino; Masashi Ishikawa; Mitsuo Obana; Nobuo Sasai; Hideaki Kaneshige; Masaaki Miyakawa; Yasushi Tanaka; Yasuo Terauchi; Ikuro Matsuba
Journal:  J Clin Med Res       Date:  2016-03-20

5.  Active participation of patients with type 2 diabetes in consultations with their primary care practice nurses - what helps and what hinders: a qualitative study.

Authors:  E du Pon; A T Wildeboer; A A van Dooren; H J G Bilo; N Kleefstra; S van Dulmen
Journal:  BMC Health Serv Res       Date:  2019-11-08       Impact factor: 2.655

6.  The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.

Authors:  Elisabetta Patorno; Mehdi Najafzadeh; Ajinkya Pawar; Jessica M Franklin; Anouk Déruaz-Luyet; Kimberly G Brodovicz; Adrian J Santiago Ortiz; Lily G Bessette; Martin Kulldorff; Sebastian Schneeweiss
Journal:  Endocrinol Diabetes Metab       Date:  2019-11-26

7.  Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China.

Authors:  Nan Zhang; Edward McNeil; Sawitri Assanangkornchai; Yancun Fan
Journal:  F1000Res       Date:  2016-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.